These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33249503)

  • 1. Severe muscle damage with myofiber necrosis and macrophage infiltrates characterize anti-Mi2 positive dermatomyositis.
    Fornaro M; Girolamo F; Cavagna L; Franceschini F; Giannini M; Amati A; Lia A; Tampoia M; D'Abbicco D; Maggi L; Fredi M; Zanframundo G; Moschetti L; Coladonato L; Iannone F
    Rheumatology (Oxford); 2021 Jun; 60(6):2916-2926. PubMed ID: 33249503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More prominent muscle involvement in patients with dermatomyositis with anti-Mi2 autoantibodies.
    Pinal-Fernandez I; Mecoli CA; Casal-Dominguez M; Pak K; Hosono Y; Huapaya J; Huang W; Albayda J; Tiniakou E; Paik JJ; Johnson C; Danoff SK; Corse AM; Christopher-Stine L; Mammen AL
    Neurology; 2019 Nov; 93(19):e1768-e1777. PubMed ID: 31594859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional derepression of CHD4/NuRD-regulated genes in the muscle of patients with dermatomyositis and anti-Mi2 autoantibodies.
    Pinal-Fernandez I; Milisenda JC; Pak K; Muñoz-Braceras S; Casal-Dominguez M; Torres-Ruiz J; Dell'Orso S; Naz F; Gutierrez-Cruz G; Duque-Jaimez Y; Matas-Garcia A; Padrosa J; Garcia-Garcia FJ; Guitart-Mampel M; Garrabou G; Trallero-Araguás E; Walitt B; Paik JJ; Albayda J; Christopher-Stine L; Lloyd TE; Grau-Junyent JM; Selva-O'Callaghan A; Mammen AL
    Ann Rheum Dis; 2023 Aug; 82(8):1091-1097. PubMed ID: 37130727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic retrospective study of 64 patients with anti-Mi2 dermatomyositis: A classic skin rash with a necrotizing myositis and high risk of malignancy.
    Monseau G; Landon-Cardinal O; Stenzel W; Schoindre Y; Mariampillai K; Barete S; Martel C; Masseau A; Meyer A; Terrier B; Guégan S; Verneuil L; Audia S; Livideanu CB; Hachulla E; Kahn JE; Lefevre G; Maurier F; Moulis G; Papo T; Dossier A; Descamps V; Salort-Campana E; Richard MA; Bergot E; Mortier L; Costedoat-Chalumeau N; Genot S; Perez F; Piette AM; Samson M; Schleinitz N; Zénone T; Lacoste M; de Boysson H; Madaule S; Rigolet A; Champtiaux N; Hervier B; Bouvier AM; Jooste V; Léonard-Louis S; Maisonobe T; Aouba A; Benveniste O; Bienvenu B; Allenbach Y;
    J Am Acad Dermatol; 2020 Dec; 83(6):1759-1763. PubMed ID: 32244015
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-SAE dermatomyositis: clinical and histologic characteristics from a monocentric Italian cohort.
    Fornaro M; Coladonato L; Giannini M; Napoletano A; Girolamo F; D'Abbicco D; Ruggieri M; Sabella DVA; Iannone F
    Clin Exp Rheumatol; 2024 Feb; 42(2):295-301. PubMed ID: 38488098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets.
    Merlo G; Clapasson A; Cozzani E; Sanna L; Pesce G; Bagnasco M; Burlando M; Parodi A
    Arch Dermatol Res; 2017 Mar; 309(2):87-95. PubMed ID: 27928683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity.
    Pinal-Fernandez I; Casal-Dominguez M; Carrino JA; Lahouti AH; Basharat P; Albayda J; Paik JJ; Ahlawat S; Danoff SK; Lloyd TE; Mammen AL; Christopher-Stine L
    Ann Rheum Dis; 2017 Apr; 76(4):681-687. PubMed ID: 27651398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct tissue injury patterns in juvenile dermatomyositis auto-antibody subgroups.
    Nguyen M; Do V; Yell PC; Jo C; Liu J; Burns DK; Wright T; Cai C
    Acta Neuropathol Commun; 2020 Aug; 8(1):125. PubMed ID: 32758284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologic Features of Anti-Mi-2 Dermatomyositis.
    Tanboon J; Inoue M; Hirakawa S; Tachimori H; Hayashi S; Noguchi S; Suzuki S; Okiyama N; Fujimoto M; Nishino I
    Neurology; 2021 Jan; 96(3):e448-e459. PubMed ID: 33277422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.
    Mariampillai K; Granger B; Amelin D; Guiguet M; Hachulla E; Maurier F; Meyer A; Tohmé A; Charuel JL; Musset L; Allenbach Y; Benveniste O
    JAMA Neurol; 2018 Dec; 75(12):1528-1537. PubMed ID: 30208379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and pathological characteristics of immune mediated necrotizing myopathy].
    Yang HX; Tian XL; Jiang W; Li WL; Liu QY; Peng QL; Wang GC; Lu X
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 51(6):989-995. PubMed ID: 31848492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscular and extramuscular features of myositis patients with anti-U1-RNP autoantibodies.
    Casal-Dominguez M; Pinal-Fernandez I; Corse AM; Paik J; Albayda J; Casciola-Rosen L; Johnson C; Danoff SK; Christopher-Stine L; Tiniakou E; Mammen AL
    Neurology; 2019 Mar; 92(13):e1416-e1426. PubMed ID: 30824556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications in the difference of anti-Mi-2 and -p155/140 autoantibody prevalence in two dermatomyositis cohorts from Mexico City and Guadalajara.
    Petri MH; Satoh M; Martin-Marquez BT; Vargas-Ramírez R; Jara LJ; Saavedra MA; Cruz-Gonzalez C; Andrade-Ortega L; Vera-Lastra O; Salazar-Páramo M; Prieto-Parra RE; Gonzalez-Lopez L; Gamez-Nava JI; Ramírez-Sánchez HU; Chan JY; Ross SJ; Chan EK; Vázquez-Del Mercado M
    Arthritis Res Ther; 2013 Apr; 15(2):R48. PubMed ID: 23557279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies in children with juvenile dermatomyositis: A single centre experience from North-West India.
    Hussain A; Rawat A; Jindal AK; Gupta A; Singh S
    Rheumatol Int; 2017 May; 37(5):807-812. PubMed ID: 28331982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological heterogeneity in a large clinical cohort of juvenile idiopathic inflammatory myopathy: analysis by myositis autoantibody and pathological features.
    Yasin SA; Schutz PW; Deakin CT; Sag E; Varsani H; Simou S; Marshall LR; Tansley SL; McHugh NJ; Holton JL; Wedderburn LR; Jacques TS;
    Neuropathol Appl Neurobiol; 2019 Aug; 45(5):495-512. PubMed ID: 30378704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Dermatomyositis Sine Dermatitis With Anti-Nuclear Matrix Protein 2 Autoantibodies.
    Inoue M; Tanboon J; Hirakawa S; Komaki H; Fukushima T; Awano H; Tajima T; Yamazaki K; Hayashi R; Mori T; Shibuya K; Yamanoi T; Yoshimura H; Ogawa T; Katayama A; Sugai F; Nakayama Y; Yamaguchi S; Hayashi S; Noguchi S; Tachimori H; Okiyama N; Fujimoto M; Nishino I
    JAMA Neurol; 2020 Jul; 77(7):872-877. PubMed ID: 32310254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.
    Srivastava P; Dwivedi S; Misra R
    Rheumatol Int; 2016 Jul; 36(7):935-43. PubMed ID: 27193471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermatomyositis: Clinical features and pathogenesis.
    DeWane ME; Waldman R; Lu J
    J Am Acad Dermatol; 2020 Feb; 82(2):267-281. PubMed ID: 31279808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Prevalence of Individual Histopathologic Features Varies according to Autoantibody Status in Muscle Biopsies from Patients with Dermatomyositis.
    Pinal-Fernandez I; Casciola-Rosen LA; Christopher-Stine L; Corse AM; Mammen AL
    J Rheumatol; 2015 Aug; 42(8):1448-54. PubMed ID: 26443871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features of anti-TIF1-α antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1-γ or anti-Mi-2 autoantibodies.
    Muro Y; Ishikawa A; Sugiura K; Akiyama M
    Rheumatology (Oxford); 2012 Aug; 51(8):1508-13. PubMed ID: 22539482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.